Recently, the Central Committee of the Communist Party of China and the State Council issued the "Healthy China 2030" plan outline, which clearly stated the need to fully leverage the advantages of traditional Chinese medicine and improve its service capabilities.
　　

According to data, in 2014, there were 3813 traditional Chinese medicine production enterprises in China, with a total industrial output value of 730.2 billion yuan. Traditional Chinese medicine has spread to 183 countries and regions, and its health and wellness concepts and technologies are gradually being recognized and applied worldwide. However, it is still a long way to go for traditional Chinese medicine. Currently, what China's traditional Chinese medicine industry can do is to start from small steps and do a good job in traditional Chinese medicine production.

The production of products cannot be separated from the application of manufacturing equipment. In the production of traditional Chinese medicine, medicinal machinery equipment plays a key role. With the standardization and improvement of domestic policies, the pharmaceutical machinery industry is facing numerous difficulties. The author explores in what directions the pharmaceutical machinery industry will strive in the future.

　　
Green and environmentally friendly production has become a major trend
　　
The concept of green and environmentally friendly production has been advocated for a long time, even in China. From shopping bags to industrial production, almost all industries are striving towards this direction. The relevant environmental policies introduced by our country also attach great importance to environmental issues, and have repeatedly proposed that the manufacturing industry should adhere to the concept of green production. As a heavily polluting enterprise, the pharmaceutical industry has been stamped with the "seal" of key supervision. Pharmaceutical equipment is the link between drugs and production, so the pharmaceutical machinery industry should strive for green environmental protection.
　　

From the processing of medicinal herbs to packaging, pharmaceutical equipment such as dryers, filling machines, packaging machines, etc. are involved. Each production and processing link corresponding to the equipment needs to be error free, pollution-free, and comply with GMP standards. This is also a great challenge for the pharmaceutical machinery industry. It is urgent to learn excellent environmental protection production technologies at home and abroad and increase research and development efforts.

　　
"Internet+manufacturing" mode has been opened
　　
In the era of Industry 4.0, compared with Germany, many manufacturing enterprises in China are still in the 2.0 and 3.0 stages, located at the middle and low ends of the value chain, facing problems such as overcapacity and resource and environmental constraints. However, China's Internet technology has developed very fast, and a large number of Internet companies have sprung up and flourished, which has brought broad imagination to the "Internet+manufacturing industry".

　　
Traditional Chinese medicine machinery and equipment often suffer from low resource utilization and high costs in the process of Chinese medicine processing and production. The pharmaceutical machinery market presents a scattered, small and chaotic state, lacking a unified and standardized production and circulation system. Based on the development of the pharmaceutical machinery industry in recent years, with the advancement of intelligent technology and the influence of the Industry 4.0 era, many pharmaceutical machinery industries in China have introduced foreign intelligent technologies, developed new intelligent mechanical equipment, and realized intelligent production lines from point to line, creating fully automated intelligent production workshops, allowing enterprises to obtain new "blood" circulation, and bringing new production vitality to pharmaceutical enterprises. However, there are not many pharmaceutical machinery enterprises in China that can achieve standardized intelligent production, and most of them are still in the research and development and pilot stages. The road ahead is still long.

　　
In the 'Made in China 2025' plan, intelligent manufacturing is the main focus, a major trend and core content for the future development of the manufacturing industry, and the fundamental path to solving the problem of China's manufacturing industry from large to strong. The road to comprehensive intelligent development in China's pharmaceutical machinery industry is still long, and the future will be even more challenging.

　　
Innovation brings vitality to the pharmaceutical machinery industry
　　
Innovation drives development, technology achieves the future. In China's pharmaceutical machinery industry, there is a lack of intellectual property awareness among competitors. For example, if a certain pharmaceutical equipment becomes popular, other pharmaceutical machinery companies will imitate each other and manufacture a large number of imitation equipment to promote to the market.

　　
Lack of emphasis on protecting independent property rights will inevitably lead to market chaos. Simply relying on copy and paste is not feasible, as it will not only dampen the enthusiasm of pharmaceutical machinery enterprises for innovation and research, but also hinder the development of the pharmaceutical machinery industry. Therefore, the pharmaceutical machinery industry needs to strengthen its independent innovation capabilities and activate market vitality.

　　
With the increasing popularity of personalized customization, the diverse needs of customers are testing the innovation and research and development capabilities of pharmaceutical machinery companies. Only with rich experience, a high-tech talent team, and innovative and innovative thinking can pharmaceutical machinery enterprises provide customers with satisfactory equipment. Therefore, the pharmaceutical machinery industry not only needs innovative technology, but also needs to introduce innovative talents, reserve "knowledge bags", and help enterprises develop more flexibly.